Clinical trial

A Study of Definitive Therapy to Treat Prostate Cancer

NCT02716974

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE2

Study timeline

Study start (unknown)2016-06-01Date precision: month

Registry last updated2022-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate

BicalutamideDRUG · verified · RxNorm: bicalutamide

DocetaxelDRUG · verified · RxNorm: docetaxel

ProstatectomyPROCEDURE

RadiationRADIATION

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

Mapped research locations

BaltimoreMaryland, United States2 Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02716974 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.